Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Precision therapies take aim at non-Hodgkin's lymphoma.

× No keyword cloud information.

3 in total

1. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy.

Authors: Lee A Honigberg; Ashley M Smith; Mint Sirisawad; Erik Verner; David Loury; Betty Chang; Shyr Li; Zhengying Pan; Douglas H Thamm; Richard A Miller; Joseph J Buggy
Journal: Proc Natl Acad Sci U S A Date: 2010-07-06 Impact factor: 11.205

2. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.

Authors: Ranjana H Advani; Joseph J Buggy; Jeff P Sharman; Sonali M Smith; Thomas E Boyd; Barbara Grant; Kathryn S Kolibaba; Richard R Furman; Sara Rodriguez; Betty Y Chang; Juthamas Sukbuntherng; Raquel Izumi; Ahmed Hamdy; Eric Hedrick; Nathan H Fowler
Journal: J Clin Oncol Date: 2012-10-08 Impact factor: 44.544

3. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.

Authors: James D Phelan; Ryan M Young; Daniel E Webster; Sandrine Roulland; George W Wright; Monica Kasbekar; Arthur L Shaffer; Michele Ceribelli; James Q Wang; Roland Schmitz; Masao Nakagawa; Emmanuel Bachy; Da Wei Huang; Yanlong Ji; Lu Chen; Yandan Yang; Hong Zhao; Xin Yu; Weihong Xu; Maryknoll M Palisoc; Racquel R Valadez; Theresa Davies-Hill; Wyndham H Wilson; Wing C Chan; Elaine S Jaffe; Randy D Gascoyne; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Lisa M Rimsza; Fausto J Rodriguez; Fayez Estephan; Matthias Holdhoff; Michael J Kruhlak; Stephen M Hewitt; Craig J Thomas; Stefania Pittaluga; Thomas Oellerich; Louis M Staudt
Journal: Nature Date: 2018-06-20 Impact factor: 49.962

3 in total